Springer Biochemical Modulation of Anticancer Agents Book

Explore the specialized field of biochemical modulation through this academic volume from the 18th Annual Detroit Cancer Symposium. This text examines how the intracellular metabolism of anticancer agents can be adjusted to improve medical outcomes. By using noncytotoxic agents or low-dosage cytotoxic agents, researchers aim to increase the effectiveness of treatments against tumor cells while simultaneously reducing toxicity to healthy, normal cells. This publication provides a deep look into the study of specific agents, including 5-fluorouracil (FUra), arabinofuranosylcytosine (ara-C), methotrexate (MTX), and various alkylating agents. As part of the Developments in Oncology series (Volume 47), this book serves as a detailed record of experimental and clinical approaches used to advance cancer treatment strategies. It is a valuable resource for medical professionals and researchers interested in the metabolic pathways of oncology medications.